Incyte Corp (NASDAQ:INCY)
| CAPS Rating |
|
|---|---|
| Open | $17.11 |
| Previous Close | $17.22 |
| Daily Range | $16.90 - $17.30 |
| 52-Week Range | $11.76 - $21.15 |
| Market Cap | $2.14B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 837,565 |
| Average Daily Volume | 0 |
INCY
VS S&P 500 (SPY)
How do you think INCY will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
INCY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
INCY News and Commentary
- Incyte in Neutral Lane - Analyst Blog – NASDAQ
- 3 Pharmaceutical Buyout Targets to Consider in 2012 – Blogs @ The Motley Fool
- Do the Shorts Know Something You Don't? – The Motley Fool
- Insiders Are Buying, Should We? – Blogs @ The Motley Fool
- JPMorgan Confab Kicks Off Biotech 2012 – Minyanville
- Tomorrow's Monster Stock – The Motley Fool
- Is YM the Next Incyte? – Minyanville
- You're Not the Only One Buying Here – The Motley Fool
- 5 Stocks Gaining Momentum – Blog at The Motley Fool
- Applications Given Early Antitrust Clearance – SmartMoney
- Wall Street's Best Hidden Stocks – The Motley Fool
- 2 Stocks Approaching Greatness – The Motley Fool
- Our Top Biotech Stock Idea – The Motley Fool
- Make Money in Global Health-Care Stocks the Easy Way – The Motley Fool
- In Biotech, Approval's Important, but It's the Launch That Counts – The Motley Fool
- Incyte Drug Cleared in the US - Analyst Blog – NASDAQ
- Incyte Shares Popped: What You Need to Know – The Motley Fool
- 3 Stocks Near 52-Week Lows Worth Buying – The Motley Fool
- Make Money in Health-Care Providers the Easy Way – The Motley Fool
- Mini J&J? I Guess Not – The Motley Fool
RSS Headlines
Fool UK
